Načítá se...
Immune checkpoint inhibitor—related dermatologic adverse events
Immune checkpoint inhibitors have emerged as a pillar in the management of advanced malignancies. However, nonspecific immune activation may lead to immune-related adverse events, wherein the skin and its appendages are the most frequent targets. Cutaneous immune-related adverse events include a div...
Uloženo v:
| Vydáno v: | J Am Acad Dermatol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7572894/ https://ncbi.nlm.nih.gov/pubmed/32454097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2020.03.132 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|